Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Alzheimer's Disease

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 10 articles:
HTML format
Text format



Single Articles


    March 2018
  1. DEVI G
    Alzheimer's Disease in Physicians - Assessing Professional Competence and Tempering Stigma.
    N Engl J Med. 2018;378:1073-1075.
    PubMed     Text format    


    January 2018
  2. MURPHY MP
    Amyloid-Beta Solubility in the Treatment of Alzheimer's Disease.
    N Engl J Med. 2018;378:391-392.
    PubMed     Text format    


  3. HONIG LS, Vellas B, Woodward M, Boada M, et al
    Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease.
    N Engl J Med. 2018;378:321-330.
    PubMed     Text format     Abstract available


    May 2017
  4. SACKS CA, Avorn J, Kesselheim AS
    The Failure of Solanezumab - How the FDA Saved Taxpayers Billions.
    N Engl J Med. 2017;376:1706-1708.
    PubMed     Text format    


    September 2015
  5. WARRILLOW S, Moran J, Weickhardt A
    Advanced Dementia.
    N Engl J Med. 2015;373:1276.
    PubMed     Text format    


  6. JENKINS I
    Advanced Dementia.
    N Engl J Med. 2015;373:1275-6.
    PubMed     Text format    


  7. MITCHELL SL
    Advanced Dementia.
    N Engl J Med. 2015;373:1276-7.
    PubMed     Text format    


    July 2015
  8. LANDER ES
    Brave New Genome.
    N Engl J Med. 2015;373:5-8.
    PubMed     Text format    


    June 2015
  9. TANZI RE
    TREM2 and Risk of Alzheimer's Disease - Friend or Foe?
    N Engl J Med. 2015;372:2564-5.
    PubMed     Text format     Abstract available


  10. MITCHELL SL
    CLINICAL PRACTICE. Advanced Dementia.
    N Engl J Med. 2015;372:2533-40.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: